IT1259140B - Formulazioni farmaceutiche per la somministraziane orale di calcitonina - Google Patents

Formulazioni farmaceutiche per la somministraziane orale di calcitonina

Info

Publication number
IT1259140B
IT1259140B ITPD920141A ITPD920141A IT1259140B IT 1259140 B IT1259140 B IT 1259140B IT PD920141 A ITPD920141 A IT PD920141A IT PD920141 A ITPD920141 A IT PD920141A IT 1259140 B IT1259140 B IT 1259140B
Authority
IT
Italy
Prior art keywords
calcitonin
oral administration
pharmaceutical formulations
formulations
lysogangliosides
Prior art date
Application number
ITPD920141A
Other languages
English (en)
Inventor
Lanfranco Callegaro
Luca Benedetti
Aurelio Romeo
Original Assignee
Fidia Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fidia Spa filed Critical Fidia Spa
Priority to ITPD920141A priority Critical patent/IT1259140B/it
Publication of ITPD920141A0 publication Critical patent/ITPD920141A0/it
Publication of ITPD920141A1 publication Critical patent/ITPD920141A1/it
Application granted granted Critical
Publication of IT1259140B publication Critical patent/IT1259140B/it

Links

Landscapes

  • Medicinal Preparation (AREA)

Abstract

La presente invenzione si riferisce a composizioni farmaceutiche costituite principalmente da un polipeptide, ad esempio calcitonina, e lisogangliosidi co-liofilizzati, per la somministrazione orale in forma di capsule e/o compresse gastroprotette, tali da promuovere l'assorbimento e la biodisponibilità della calcitonina senza creare scompensi biologici agli organi e tessuti che entrano in contatto con i composti impiegati nelle formulazioni.-
ITPD920141A 1992-07-30 1992-07-30 Formulazioni farmaceutiche per la somministraziane orale di calcitonina IT1259140B (it)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ITPD920141A IT1259140B (it) 1992-07-30 1992-07-30 Formulazioni farmaceutiche per la somministraziane orale di calcitonina

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITPD920141A IT1259140B (it) 1992-07-30 1992-07-30 Formulazioni farmaceutiche per la somministraziane orale di calcitonina

Publications (3)

Publication Number Publication Date
ITPD920141A0 ITPD920141A0 (it) 1992-07-30
ITPD920141A1 ITPD920141A1 (it) 1994-01-30
IT1259140B true IT1259140B (it) 1996-03-11

Family

ID=11390033

Family Applications (1)

Application Number Title Priority Date Filing Date
ITPD920141A IT1259140B (it) 1992-07-30 1992-07-30 Formulazioni farmaceutiche per la somministraziane orale di calcitonina

Country Status (1)

Country Link
IT (1) IT1259140B (it)

Also Published As

Publication number Publication date
ITPD920141A0 (it) 1992-07-30
ITPD920141A1 (it) 1994-01-30

Similar Documents

Publication Publication Date Title
NZ228130A (en) Therapeutic composition comprising fenofibrate and a solid surfactant which has been co-micronised; preparatory process
EP0552256A4 (it)
UA32512C2 (uk) Похідні ксантину, спосіб їх одержання, та фармацевтична композиція
GR3004448T3 (it)
ZA888734B (en) Stabilized medicinal substances,a process for the preparation thereof,and stable medicinal formulations
ATE99941T1 (de) Medikamente enthaltend salmeterol und fluticason.
GEP20053473B (en) High Potency Dihydroergotamine Compositions
HUT59306A (en) Process for producing pharmaceutical compositions comprising l-carnitine
ATE224717T1 (de) Oral anzuwendende arzneizubereitungen enthaltend eine benzhydrylpiperazine und eine zyklodextrin
ZA905861B (en) Pharmaceutical composition for oral administration containing nac
CA2038744A1 (en) Pharmaceutical composition containing slightly water-soluble drug
DE59811768D1 (de) Pharmazeutische kombinationspräparate enthaltend erythropoietin und modifizierte hämoglobine
DE69004532D1 (de) Topisch anzuwendende Defibrotid enthaltende Arzneizubereitungen.
GR890100833A (en) Process for the preparation of a compound with gastric inhibitopy effect
FR2651435B1 (it)
EP0230264A3 (en) Pharmaceutical composition for nasal application, process for its preparation and its use
IL85963A0 (en) Pharmaceutical compositions for the prophylaxis or treatment of disorders or diseases of the gastrointestinal tract,comprising antigenic substances
AU536582B2 (en) Plenylpiperazine derivatives of 1,3,4-oxiadiazolylphends
IT1259140B (it) Formulazioni farmaceutiche per la somministraziane orale di calcitonina
GR3018365T3 (en) Use of 15-deoxyspergualine as a medicament.
HK135494A (en) Azelastin embonate, process for its preparation and pharmaceutical compositions containing azelastin embonate as the active ingredient
UA32583C2 (uk) Похідні арилтіоалкілтіопіридину
IE883402L (en) Azelastine embonate, processes for its preparation and pharmaceutical formulations which contain azelastine embonate as active substance
HUP0100634A2 (hu) Pentaeritrit-tetranitrátot tartalmazó gyógyászati készítmények
FR2592793A1 (fr) Association de sulpiride et de diazepam a titre de composition pharmaceutique, notamment utile dans le traitement des manifestations fonctionnelles digestives liees au stress, et son utilisation pour la preparation de ladite composition.

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19960701